1215857_-_Agilent_Tech_Inc_-_Sole_Source_Notice.doc

DOC document 54 KB Posted Jul 9, 2019

Attached to: Maintenance and Repair for Agilent LC-MS system and G6120B Single Quadrupole
Solicitation number: 1215857
Issued by: Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services

View the file

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

FDA-Sole Source-1215857 Maintenance and Repair for an Agilent LC-MS system, Model 1290 Infinity !! and G6120B Single Quadrupole

Document Type:

Notice of Intent to Sole Source

Solicitation Number:

FDA - Sole Source - 1215857

Posted Date:

9 July 2019

Response Date:

16 July 2019

NAICS Code:

334516, Analytical Laboratory Instrument Manufacturing, Small Size Standard 1,000 Employees.

The Food and Drug Administration intends to make a sole source award for a maintenance and repair contract for an Agilent liquid chromatography – Mass spectrometer system, Model 1290 Infinity II and G6120B Single Quadrupole. The award will be made to:

Agilent Technologies, Inc.

2850 Centerville Road Wilmington, DE 19808 In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements.

Agilent Technologies, Inc. is the manufacturer of the equipment and their service engineers are trained to maintain and repair their equipment. Agilent Technologies, Inc. has the required trained personnel, immediate access to parts, and technical knowledge needed to efficiently support their own equipment better than a third-party source. This equipment is both sensitive and expensive and need to be maintained by the most qualified available support group. The technicians must be completely familiar and trained to work on this equipment. Agilent Technologies, Inc are the only vendor who can provide the availability of trained personnel as well as the immediate access to parts to provide the quality of service needed.

This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within five (5) days after the publication of this synopsis which shall be considered by the agency. Responses received after 5 days or without the required information may not be considered. For information concerning this acquisition contact:

Nikola Zuber Contract Specialist Nikola.Zuber@fda.hhs.gov

(301) 796 - 9671 A determination by the Government not to compete because of information received is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement.

1 | Page

File details come from the government source that posted it.